Vikram Raghunathan
Overview
Explore the profile of Vikram Raghunathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samples L, Sadrzadeh H, Frigault M, Jacobson C, Hamadani M, Gurumurthi A, et al.
Blood
. 2025 Feb;
PMID: 39938007
Burkitt lymphoma (BL) is an aggressive B-cell lymphoma associated with poor outcomes in patients with relapsed/refractory disease. This multicenter, retrospective study evaluated real-world CD19 CAR T-cell therapy outcomes in patients...
2.
Hatashima A, Shadman M, Raghunathan V
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858050
Pathway inhibitors targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma-2 (BCL-2) have dramatically changed the treatment landscape for both treatment-naïve and relapsed/refractory chronic lymphocytic leukemia (CLL). However, with increased utilization,...
3.
Lyski Z, Kim M, Xthona Lee D, Sampson D, Raue H, Raghunathan V, et al.
Case Rep Hematol
. 2022 Feb;
2022:6831640.
PMID: 35127183
Individuals with chronic lymphocytic leukemia (CLL) have significant immune disfunction, often further disrupted by treatment. While currently available COVID-19 vaccinations are highly effective in immunocompetent individuals, they are often poorly...
4.
Lyski Z, Kim M, Xthona Lee D, Raue H, Raghunathan V, Griffin J, et al.
Blood Adv
. 2021 Dec;
6(4):1207-1211.
PMID: 34872103
No abstract available.
5.
Oakes M, Arastu A, Kato C, Somers J, Holly H, Elstrott B, et al.
Thromb Res
. 2021 Sep;
207:96-98.
PMID: 34592628
Erythrocytosis is a well-recognized consequence of exogenous testosterone, however its prevalence and contributions to thrombosis remain unknown in the context of gender-affirming hormonal therapy. We undertook a retrospective study of...
6.
Orellana-Noia V, Reed D, McCook A, Sen J, Barlow C, Malecek M, et al.
Blood
. 2021 Sep;
139(3):413-423.
PMID: 34570876
Prophylaxis is commonly used to prevent central nervous sy stem (CNS) relapse in diffuse large B-cell lymphoma (DLBCL), with no clear standard of care. We retrospectively evaluated 1162 adult patients...
7.
Lyski Z, Kim S, Xthona Lee D, Sampson D, Raue H, Raghunathan V, et al.
medRxiv
. 2021 Sep;
PMID: 34518841
Importance: Individuals with Chronic Lymphocytic Leukemia have significant immune disfunction, often further disrupted by treatment. While currently available COVID-19 vaccinations are highly effective in immunocompetent individuals, they are often poorly...
8.
Kohs T, Liu P, Raghunathan V, Amirsoltani R, Oakes M, McCarty O, et al.
Platelets
. 2021 Aug;
33(4):570-576.
PMID: 34355646
Extracorporeal membrane oxygenation (ECMO) provides lifesaving circulatory support and gas exchange, although hematologic complications are frequent. The relationship between ECMO and severe thrombocytopenia (platelet count <50 × 10/L) remains ill-defined....
9.
Raghunathan V, Liu P, Kohs T, Amirsoltani R, Oakes M, McCarty O, et al.
ASAIO J
. 2021 Feb;
67(8):899-906.
PMID: 33528163
Extracorporeal membrane oxygenation (ECMO) protocols generally require systemic anticoagulation with heparin to prevent circuit thrombosis. The prevalence, risk factors, and outcomes of heparin resistance in this setting are ill-defined. To...
10.
Reitsma S, Pang J, Raghunathan V, Shatzel J, Lorentz C, Tucker E, et al.
Am J Physiol Cell Physiol
. 2021 Jan;
320(3):C365-C374.
PMID: 33471623
Factor XI (FXI) has been shown to bind platelets, but the functional significance of this observation remains unknown. Platelets are essential for hemostasis and play a critical role in thrombosis,...